FDA issued a Warning Letter to Park Infusioncare LP dba Preferred Homecare on 3/1/2018 as a result of this inspection.
483 Park Infusioncare LP dba Preferred Homecare Jul 2017
483 Park Infusioncare LP dba Preferred Homecare Jul 2017
Anh Lac FDA$119.00 - Available NowFDA investigators audited the Park Infusioncare LP dba Preferred Homecare - Dallas, TX, United States facility and issued 4 inspectional observations (via FDA 483) on 11 Jul 2017.
Product details
- Category: Human Drugs
- Number of Observations: 4
- Inspection end: 11 Jul 2017
- Location: Dallas, United States
- FEI: 3013330273
Add To Cart